nach oben

Current Cardiovascular Imaging Reports

Erschienen in:

01.11.2015 | Echocardiography (T Buck, Section Editor)

Imaging During Percutaneous Valvular Heart DiseaseInterventions: Is More Better or Less?

verfasst von: Alejandra Carbonell San Román, José Luis Zamorano Gómez

Erschienen in: Current Cardiovascular Imaging Reports | Ausgabe 11/2015

Einloggen, um Zugang zu erhalten

Abstract

Percutaneous valvular interventions have become a valid option in the treatment of valvular heart disease (VHD) for patients with prohibited surgical risk and multiple comorbidities. Multimodality imaging plays an increasingly central role in the evaluation of these interventions in which precise guidance for appropriate and accurate positioning of the device is mandatory. This review will discuss the role of these imaging modalities in patient selection and the pre-procedural assessment of the valve, intra-procedural guidance and, ultimately, result evaluation.

Vahanian A, Alfieri O, Adreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012): the joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2012;33:2451–96.PubMedCrossRef

Vahanian A, Alfieri O, Al-Attar N, Antus M, Bax J, Cormier B, et al. Transcathether valve implantation for patients with aortic stenosis: position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2008;29:1463–70.PubMedCrossRef

Gurvitch R, Webb JG, Yuan R, Johnson M, Hague C, Wilson AB, et al. Aortic annulus diameter determination by multidetector computed tomography: reproducibility, applicability, and implications for transcatheter aortic valve implantation. J Am Coll Cardiol Intv. 2011;4(11):1235–45.CrossRef

Bloomfield GS, Gillam LD, Hahn RT, Kapadia S, Leipsic J, Lerakis S, et al. A practical guide to multimodality imaging of transcatheter aortic valve replacement. J Am Coll Cardiol Img. 2012;5(4):441–55.CrossRef

5.••

Zamorano JL, Badano LP, Bruce C, Chan KL, Gonçalves A, Hahn RT, et al. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. Eur Heart J. 2011;32(17):2189–214. This is one of the first expert consensus documents underlining the importance of echocardiography in the guidance of transcatheter valve procedures and its role in patient selection, preprocedural planning, intraprocedural support and postprocedural evaluation.PubMedCrossRef

Thomas M, Schymik G, Walther T, Himbert D, Lefevre T, Treede H, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2011;124:425–33.PubMedCrossRef

Bax J, Delgado V, Bapat V, Baumgartner H, Collet JP, Erbel R, et al. Open issues in transcatheter aortic valve implantation. Part 2: procedural issues and outcomes after transcatheter aortic valve implantation. Eur Heart J. 2014;35:2627–38.PubMedCrossRef

Khatri PJ, Webb JG, Rodes-Cabau J, Fremes SE, Ruel M, Lau K, et al. Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies. Ann Intern Med. 2013;158:35–46.PubMedCrossRef

Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin 3rd JP, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(23):e521–643.PubMedCrossRef

10.

Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366:1705–15.PubMedCrossRef

11.

Moat NE, Ludman P, de Belder MA, Bridgewater B, Cunningham AD, Young CP. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the UK TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol. 2011;58:2130–8.PubMedCrossRef

12.

Mack MJ, Brennan JM, Brindis R, Carroll J, Edwards F, Grover F, et al. Outcomes following transcatheter aortic valve replacement in the United States. JAMA. 2013;310:2069–77.PubMedCrossRef

13.•

Athappan G, Patvardhan E, Tuzcu EM, Svensson LG, Lemos PA, Fraccaro C. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol. 2013;61:1585–95. A meta-analysis to report predictors of paravalvular regurgitation being mostly the Agatson calcium score by MSCT, valve undersizing and the depth of implantation.PubMedCrossRef

14.•

Smith LA, Monaghan MJ. Monitoring of procedures: peri-interventional echo assessment for transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging. 2013;14(9):840–50. An excellent review to describe the procedural use of echocardiography and its added value in this procedure.PubMedCrossRef

15.

Jánosi RA, Kahlert P, Plicht B, Wendt D, Eggebrecht H, Erbel R, et al. Measurement of the aortic annulus size by real-time three-dimensional transesophageal echocardiography. Minim Invasive Ther. 2011;20:85–94.CrossRef

16.

Jabbour A, Ismail TF, Moat N, Gulati A, Roussin I, Alpendurada F, et al. Multimodality imaging in transcatheter aortic valve implantation and post-procedural aortic regurgitation: comparison among cardiovascular magnetic resonance, cardiac computed tomography, and echocardiography. J Am Coll Cardiol. 2011;58:2165–73.PubMedCrossRef

17.

Gurvtich R, Webb JG, Yuan R, Johnson M, Hague C, Willson AB, et al. Aortic annulus diameter determination by multidetector computed tomography: reproducibility, applicability and implications for transcatheter aortic valve implantation. J Am Coll Cardiol Intv. 2011;4(11):1235–45.CrossRef

18.

Jilaihawi H, Kashif M, Fontana G, Furugen A, Shiota T, Friede G, et al. Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation. J Am Coll Cardiol. 2012;59(14):1275–86.PubMedCrossRef

19.

Watanabe Y, Morice MC, Bouvier E, Leong T, Hayashida K, Lefèvre T, et al. Automated 3-dimensional aortic annular assessment by multidetector computed tomography in transcatheter aortic valve implantation. J Am Coll Cardiol Intv. 2013;6(9):955–64.CrossRef

20.

Altiok E, Koos R, Schroder J, Brehmer K, Hamada S, Becker M, et al. Comparison of two-dimensional and three-dimensional imaging techniques for measurement of aortic annulus diameters before transcatheter aortic valve implantation. Heart. 2011;91(19):1578–84.CrossRef

21.

Stortecky S, Heg D, Gloekler S, Wenaweser P, Windecker S, Buellesfeld L. Accuracy and reproducibility of aortic annulus sizing using a dedicated three-dimensional computed tomography reconstruction tool in patients evaluated for transcatheter aortic valve replacement. EuroIntervention. 2014;10(3):339–46.PubMedCrossRef

22.

Khalique OK, Kodali SK, Paradis JM, Nazif TM, Williams MR, Einstein AJ, et al. Aortic annular sizing using a novel 3-dimensional echocardiographic method: use and comparison with cardiac computed tomography. Circ Cardiovasc Imaging. 2014;7(1):155–63.PubMedCrossRef

23.

Santos N, de Agustin JA, Almeria C, Goncalves A, Marcos-Alberca P, Fernandez-Golfin C, et al. Prosthesis/annulus discongruence assessed by three-dimensional transesophageal echocardiography: a predictor of significant para valvular aortic regurgitation after transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging. 2012;13:931–7.PubMedCrossRef

24.

Hahn T, Khalique O, Williams MR, et al. Predicting paravalvular regurgitation following transcatheter valve replacement: utility of a novel method for three-dimensional echocardiographic measurement of the aortic annulus. J Am Soc Echocardiogr. 2013;26:144–52.

25.

Thilo C, Shivaraju A, von Scheidt W, Kasel AM. Bicuspid aortic valve stenosis with successful transfemoral transcatheter aortic valve replacement (TAVI) using the Sapien 3 valve. Eur Heart J. 2014;35(38):2662.PubMedCrossRef

26.

Costopoulos C, Latib A, Maisano F, Testa L, Bedogni F, Buchanan L, et al. Comparison of results of transcatheter aortic valve implantation in patients with severely stenotic bicuspid versus tricuspid or nonbicuspid valves. Am J Cardiol. 2014;113(8):1390–3.PubMedCrossRef

27.

Ewe SH, Ng AC, Schuijf JD, van der Kley F, Colli A, Palmen M, et al. Location and severity of aortic valve calcium and implications for aortic regurgitation after transcatheter aortic valve implantation. Am J Cardiol. 2011;108:1470–7.PubMedCrossRef

28.

Haensig M, Lehmkuhl L, Rastan AJ, Kempfert J, Mukherjee C, Gutberlet M, et al. Aortic valve calcium scoring is a predictor of significant paravalvular aortic insufficiency in transapical-aortic valve implantation. Eur J Cardiothorac Surg. 2012;41:1234–40.PubMedCrossRef

29.

Ribeiro HB, Nombela-Franco L, Urena M, Mok M, Pasian S, Doyle D, et al. Coronary obstruction following transcatheter aortic valve implantation: a systematic review. J Am Coll Cardiol Intv. 2013;6(5):452–61.CrossRef

30.

Jánosi RA, Plicht B, Kahlert P, Eißmann M, Wendt D, Jakob H, et al. Quantitative analysis of aortic valve stenosis and aortic root dimensions by three-dimensional echocardiography in patients scheduled for transcutaneous aortic valve implantation. Curr Cardiovasc Img Rep. 2014;7:9296.CrossRef

31.

Barbanti M, Yang TH, Rodes-Cbau J, Tamburin C, Jilaihawi H, et al. Anatomical and procedural features associated with aortic root rupture during balloon expandable transcatheter aortic valve replacement. Circulation. 2013;128(3):244–53.PubMedCrossRef

32.

Masson JB, Kovac J, Schuler G, Ye J, Cheung A, Kapadia S, et al. Transcatheter aortic valve implantation: review of the nature, management and avoidance of procedural complications. J Am Coll Cardiol Intv. 2009;2(9):811–20.CrossRef

33.

Holmes Jr DR, Mack MJ, Kaul S, Agnihotri A, Alexander KP, Bailey SR, et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol. 2012;59(2):249–62.

34.•

Zamorano JL, Gonçalves A, Lang R. Imaging to select and guide transcatheter aortic valve implantation. Eur Heart J. 2014;35:1578–87. The use of multimodality imaging in percutaneous valve interventions is described in detail in this review.PubMedCentralPubMedCrossRef

35.

Shibayama K, Harada K, Berdejo J, Mihara H, Tanaka J, Gurudevan SV, et al. Effect of transcatheter aortic valve replacement on the mitral valve apparatus and mitral regurgitation: real-time three-dimensional transesophageal echocardiography study. Circ Cardiovasc Imaging. 2014;7(2):344–51.PubMedCrossRef

36.

Lerakis S, Hayek SS, Douglas PS. Paravalvular aortic leak after transcatheter aortic valve replacement: current knowledge. Circulation. 2013;127(3):397–407.PubMedCrossRef

37.

Hong SJ, Hong MK, Ko YG, Hong GR, Shim JK, Kwak YL, et al. Migration of calcium and atheromatous plaque in computed tomography: an important mechanism of coronary artery occlusion after transcatheter aortic valve replacement. J Am Coll Cardiol. 2014;63(12):e23.PubMedCrossRef

38.

Ribeiro HB, Webb JG, Makkar RR, Cohen MG, Kapadia SR, Kodali S, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicentre registry. J Am Coll Cardiol. 2013;62(17):1552–62.PubMedCrossRef

39.

Griese DP, Reents W, Kerber S, Diegeler A, Babin-Ebell J. Emergent cardiac surgery during transfemoral and transapical transcatheter aortic valve implantation: incidence, reasons, management and outcome of 411 patients from a single center. Catheter Cardiovasc Interv. 2013;82(5):E726–33.PubMedCrossRef

40.

Eggebrecht H, Schmermund A, Kahlert P, Erbel R, Voigtlander T, Mehta RH. Emergent cardiac surgery during transcatheter aortic implantation (TAVI): a weighted meta-analysis of 9251 patients from 46 studies. Eurointervention. 2013;8(9):1072–80.PubMedCrossRef

41.

Zoghbi WA, Chambers JB, Dumesnil JG, Foster E, Gottdiener JS, Grayburn PA, et al. Recommendations for evaluation of prosthetic valves with echocardiography and Doppler ultrasound: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society Of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2009;22(9):975–1014.PubMedCrossRef

42.•

Goncalves A, Almeria C, Marcos-Alberca P, Feltes G, Hernandez-Antolin R, Rodriguez E, et al. Three-dimensional echocardiography in paravalvular aortic regurgitation assessment after transcatheter aortic valve implantation. J Am Soc Echocardiogr. 2012;25:47–55. This paper describes the incremental value of three-dimensional echocardiography in assessment of paravalvular regurgitation.PubMedCrossRef

43.

Sinning JM, Vasa-Nicotera M, Chin D, Hammerstingl C, Ghanem A, Bence J, et al. Evaluation and management of paravalvular aortic regurgitation after transcatheter aortic valve replacement. J Am Coll Cardiol. 2013;62(1):11–20.PubMedCrossRef

44.

Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg. 2012;42(5):S45–60.PubMedCrossRef

45.

Lang RM, Badano LP, Tsang W, Adams DH, Agricola E, Buck T, et al. EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. Eur Heart J Cardiovasc Imaging. 2012;13(1):1–46.PubMedCrossRef

46.•

Genereux P, Head SJ, Hahn R, Daneault B, Odali S, Williams MR, et al. Paravalvular leak after transcatheter aortic valve replacement: the new Achilles’ heel: a comprehensive review of the literature. J Am Coll Cardiol. 2013;61(11):1125–36. This paper resumes the evidence provided by current literature on paravalvular regurgitation.PubMedCrossRef

47.

Nombela-Franco L, Rodes-Cabau J, DeLarochelliere R, Larose E, Doyle D, Villeneuve J, et al. Predictive factors, efficacy and safety of balloon post-dilatation after transcatheter aortic valve implantation with a balloon-expandable valve. J Am Coll Cardiol Intv. 2012;5:499–512.CrossRef

48.

Nietlispach F, Maisano F. Balloon post-dilation after transcatheter aortic valve replacement: a solution worth trying in patients with residual aortic insufficiency. J Am Coll Cardiol Intv. 2014;7(7):790–1.CrossRef

49.

Daneault B, Koss E, Hahn RT, Kodali S, Williams MR, Genereux P, et al. Efficacy and safety of postdilatation to reduce paravalvular regurgitation during balloon-expandable transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2013;6(1):85–91.PubMedCrossRef

50.

Inoue K. Percutaneous transvenous mitral commissurotomy using the Inoue balloon. Eur Heart J. 1991;99(Suppl B):99–108.CrossRef

51.

Wilkins GT, Weyman AE, Abascal VM, Block PC, Palacios IF. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J. 1988;60(4):299–308.PubMedCentralPubMedCrossRef

52.

Valocik G, Kamp O, Mannaerts HF, Visser CA. New quantitative three-dimensional echocardiographic indices of mitral valve stenosis. Int J Cardiovasc Imaging. 2007;23(6):707–16.PubMedCrossRef

53.

Zamorano J, Cordeiro P, Sugeng L, et al. Real-time three-dimensional echocardiography for rheumatic mitral valve stenosis evaluation—an accurate and novel approach. J Am Coll Cardiol. 2004;43(11):2091–6.PubMedCrossRef

54.

Fatkin D, Roy P, Morgan JJ, Feneley MP. Percutaneous balloon mitral valvulotomy with the Inoue single-balloon catheter: commissural morphology as a determinant of outcome. J Am Coll Cardiol. 1993;21(2):390–7.PubMedCrossRef

55.

Dreyfus J, Cimadevilla C, Nguyen V, Brochet E, Lepage L, Himbert D, et al. Feasibility of percutaneous mitral commissurotomy in patients with commissural mitral valve calcification. Eur Heart J. 2014;35(24):1617–23.PubMedCrossRef

56.

White ML, Grover-McKay M, Weiss RM, et al. Prediction of change in mitral valve area after mitral balloon commissurotomy using cine computed tomography. Investig Radiol. 1994;29(9):827–33.CrossRef

57.

Zamorano J, Perez de Isla L, Sugeng L, et al. Non-invasive assessment of mitral valve area during percutaneous balloon mitral valvuloplasty: role of real-time 3D echocardiography. Eur Heart J. 2004;25(23):2086–91.PubMedCrossRef

58.

Applebaum RM, Kasliwal RR, Kanojia A, et al. Utility of three-dimensional echocardiography during balloon mitral valvuloplasty. J Am Coll Cardiol. 1998;32:1405–9.PubMedCrossRef

59.

Lee S-P, Kim H-K, Kim K-H, Kim J-H, et al. Prevalence of significant tricuspid regurgitation in patients with successful percutaneous mitral valvuloplasty for mitral stenosis: results from 12 years’ follow-up of one centre prospective registry. Heart. 2013;99:91–7.PubMedCrossRef

60.

Feldman T, Kar S, Rinaldi M, et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol. 2009;54:686–94.PubMedCrossRef

61.

Feldman T, Foster E, Glower DG, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364:1395–406.PubMedCrossRef

62.

Munkholm-Larsen S, Wan B, Tian DH, Kearney K, Rahnavardi M, Dixen U, et al. A systematic review on the safety and efficacy of percutaneous edge-to-edge mitral valve repair with the MitraClip system for high surgical risk candidates. Heart. 2014;100(6):473–8.PubMedCrossRef

63.

Wan B, Rahnavardi M, Tian DH, Phan K, Munkholm-Larsen S, Bannon PG, et al. A meta-analysis of MitraClip system versus surgery for treatment of severe mitral regurgitation. Ann Cardiothorac Surg. 2013;2(6):683–92.PubMedCentralPubMed

64.

Alfieri O, De Bonis M. The role of edge-to-edge repair in the surgical treatment of mitral regurgitation. J Card Surg. 2010;25(5):536–41.PubMedCrossRef

65.

Wunderlich NC, Siegel RJ. Peri-interventional echo assessment for the MitraClip procedure. Eur Heart J Cardiovasc Imaging. 2013;14(10):935–49.PubMedCrossRef

66.

Quaife RA, Salcedo EE, Carroll JD. Procedural guidance using advance imaging techniques for percutaneous edge-to-edge mitral valve repair. Curr Cardiol Rep. 2014;16(2):452.PubMedCrossRef

67.

Jain S, Malouf JF. Incremental value of 3-D transesophageal echocardiographic imaging of the mitral valve. Curr Cardiol Rep. 2014;16(1):439.PubMedCrossRef

68.

Lancellotti P, Moura L, Pierard LA, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr. 2010;11:307–32.PubMedCrossRef

69.

Biner S, Rafique A, Rafii G, Tolstrup K, Noorani O, Shiota T. Reproducibility of proximal isovelocity surface area, vena contracta and regurgitant jet area for assessment of mitral regurgitation severity. J Am Coll Cardiol Img. 2010;3:235–43.CrossRef

70.

Kahlert P, Plicht B, Schenk IM, Janosi A, Erbel R, Buck T. Direct assessment of size and shape of non-circular vena contracta area in functional versus organic mitral regurgitation using real-time three-dimensional echocardiography. J Am Soc Echocardiogr. 2008;21(8):912–21.PubMedCrossRef

71.

de Agustín JA, Marcos-Alberca P, Fernandez-Golfin C, Gonçalves A, Feltes G, Nuñez-Gil IJ, et al. Direct measurement of proximal isovelocity surface area by single-beat three-dimensional color Doppler echocardiography in mitral regurgitation: a validation study. J Am Soc Echocardiogr. 2012;25(8):815–23.PubMedCrossRef

72.

Faletra FF, Pedrazzini G, Pasotti E, Petrova I, Drasutiene A, Dequarti MC, et al. Role of real-time three dimensional transoesophageal echocardiography as guidance imaging modality during catheter based edge-to-edge mitral valve repair. Heart. 2013;99(16):1204–15.PubMedCrossRef

73.

Biner S, Perk G, Kar S, Rafique AM, Slater J, Shiota T, et al. Utility of combined two-dimensional and three-dimensional transesophageal imaging for catheter-based mitral valve clip repair of mitral regurgitation. J Am Soc Echocardiogr. 2011;24(6):611–7.PubMedCrossRef

74.

Carpentier A, Chauvaud S, Fabiani JN, Deloche A, Relland J, Lessana A, et al. Reconstructive surgery of mitral valve incompetence: ten-year appraisal. J Thorac Cardiovasc Surg. 1980;79:338–48.PubMed

75.

Paranskaya L, D’Ancona G, Bozdag-Turan I, Akin I, Kische S, Turan GR, et al. Percutaneous mitral valve repair with the MitraClip system: perioperative and 1-year follow-up results using standard or multiple clipping strategy. Catheter Cardiovasc Interv. 2013;81(7):1224–31.PubMedCrossRef

76.

Altiok E, Hamada S, Brehmer K, et al. Analysis of procedural effects of percutaneous edge-to-edge mitral valve repair by 2D and 3D echocardiography. Circ Cardiovasc Imaging. 2012;5:748–55.PubMedCrossRef

77.

Zamorano JL, Badano LP, Bruce C, et al. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. Eur J Echocardiogr. 2011;12:557–84.PubMedCrossRef

78.

Ciobanu A, Bennett S, Azam M, Clark A, Vinereanu D. Incremental value of three-dimensional transoesophageal echocardiography for guiding double percutaneous MitraClip ® implantation in a ‘no option’ patient. Eur J Echocardiogr. 2011;12(2):E11.PubMedCrossRef

79.

Lin BA, Forouhar AS, Pahlevan NM, Anastassiou CA, Grayburn PA, Thomas JD, et al. Color Doppler jet area overestimates regurgitant volume when multiple jets are present. J Am Soc Echocardiogr. 2010;23(9):993–1000.PubMedCrossRef

80.

Blumlein S, Bouchard A, Schiller NB, Dae M, Byrd 3rd BF, Ports T, et al. Quantitation of mitral regurgitation by Doppler echocardiography. Circulation. 1986;74(2):306–14.PubMedCrossRef

81.

Buck T, Thiele KE. Basic principles and practical application. In: Buck T, Monaghan MJ, Franke A, editors. Three-dimensional echocardiography. 2nd ed. Heidelberg: Springer; 2015.

82.

Faletra FF, Ramamurthi A, Dequarti MC, Leo LA, Moccetti T, Pandian N. Artifacts in three-dimensional transoesophageal echocardiography. J Am Soc Echocardiogr. 2014;27(5):453–62.PubMedCrossRef

83.

Gafoor S, Schulz P, Heuer L, Matic P, Franke J, Bertog S, et al. Use of EchoNavigator, a novel echocardiography-fluoroscopy overlay system, for transeptal puncture and left atrial appendage occlusion. J Interv Cardiol. 2015;28:215–7.PubMedCrossRef

84.

Sündermann SH, Biaggi P, Grünenfelder J, Gessat M, Felix C, Bettex D, et al. Safety and feasibility of novel technology fusing echocardiography and fluoroscopy images during MitraClip interventions. EuroIntervention. 2014;9(10):1210–6.PubMedCrossRef

85.

Ionescu A, Fraser AG, Butchart EG. Prevalence and clinical significance of incidental paraprosthetic valvular regurgitation: a prospective study using transoesophageal echocardiography. Heart. 2003;89:1316–21.PubMedCentralPubMedCrossRef

86.

Defterios S, Giannopoulos G, Raisakis K, Kaoukis K, Kossyvakis C. Intracardiac echocardiography imaging of periprosthetic valvular regurgitation. Eur J Echocardiogr. 2010;11:E20.CrossRef

87.

Taramasso M, Maisano F, Latib A, Denti P, Guidotti A, Sticchi A, et al. Conventional surgery and transcatheter closure via surgical transapical approach for paravalvular leak repair in high-risk patients: results from a single-centre experience. Eur Heart J Cardiovasc Imaging. 2014;15(10):1161–7.PubMedCrossRef

88.

Nietlispach F, Johnson M, Moss RR, Wijesinghe N, Gurvitch R, Tay ELW, et al. Transcatheter closure of paravalvular defects using a purpose-specific occluder. J Am Coll Cardiol Intv. 2010;3:759–65.CrossRef

89.••

Kliger C, Eiros R, Isasti G, et al. Review of surgical prosthetic paravalvular leaks: diagnosis and catheter-based closure. Eur Heart J. 2013;34:638–49. A technical approach to management of paravalvular leak closure with special description of imaging techniques and its use in these interventions.PubMedCrossRef

90.

Garcia-Fernandez MA, Cortes M, Garcia-Robles JA, Gomez de Diego JJ, Perez-David E, Garcia E. Utility of real-time three-dimensional transesophageal echocardiography in evaluating the success of percutaneous transcatheter closure of mitral paravalvular leaks. J Am Soc Echocardiogr. 2010;23:26–32.PubMedCrossRef

91.

Lázaro C, Hinojar R, Zamorano JL. Cardiac imaging in prosthetic paravalvular leaks. Cardiovasc Diagn Ther. 2014;4(4):307–13.PubMedCentralPubMed

92.

Lesser JR, Han BK, Newell M, Schwartz RS, Pedersen W, Sorajja P. Use of cardiac CT angiography to assist in the diagnosis and treatment of aortic prosthetic paravalvular leak: a practical guide. J Cardiovasc Comput Tomogr. 2014;S1934-5925(14):00296–2.

93.••

Pibarot P, Hahn RT, Weissman NJ, Monaghan MJ. Assessment of paravalvular regurgitation following TAVR: a proposal of unifying grading scheme. J Am Coll Cardiol Img. 2015;8(3):340–60. Recent expert consensus which proposed a new scheme to grade paravalvular regurgitation after TAVI describing the method and reasons to support the proposed grading scheme.CrossRef

94.

Kim MS, Casserly IP, Garcia JA, et al. Percutaneous transcatheter closure of prosthetic mitral paravalvular leaks: are we there yet? J Am Coll Cardiol Intv. 2009;2:81–90.CrossRef

95.

Becerra JM, Almeria C, de Isla LP, Zamorano J. Usefulness of 3D transoesophageal echocardiography for guiding wires and closure devices in mitral perivalvular leaks. Eur J Echocardiogr. 2009;10:979–81.PubMedCrossRef

96.

Biner S, Kar S, Siegel RJ, Rafique A, Shiota T. Value of color Doppler three-dimensional transesophageal echocardiography in the percutaneous closure of mitral prosthesis paravalvular leak. Am J Cardiol. 2010;105(7):984–9.PubMedCrossRef

97.

De Cicco G, Russo C, Moreo A, Beghi C, Fucci C, Gerometta P, et al. Mitral valve periprosthetic leakage: anatomical observations in 135 patients from a multicentre study. Eur J Cardiothorac Surg. 2006;30(6):887–91.PubMedCrossRef

98.

Franco E, Almería C, de Agustín JA, Arreo Del Val V, de Diego JJ G, García Fernández MA, et al. Three-dimensional color Doppler transesophageal echocardiography for mitral paravalvular leak quantification and evaluation of percutaneous closure success. J Am Soc Echocardiogr. 2014;27(11):1153–63.PubMedCrossRef

99.

Ribeiro HB, Le Ven F, Larose E, Dahou A, Nombela-Franco L, Urena M, et al. Cardiac magnetic resonance versus transthoracic echocardiography for the assessment and quantification of aortic regurgitation in patients undergoing transcatheter aortic valve implantation. Heart. 2014;100(24):1924–32.PubMedCrossRef

100.

Orwat S, Diller GP, Kaleschke G, Kerckhoff G, Kempny A, Radke RM, et al. Aortic regurgitation severity after transcatheter aortic valve implantation is underestimated by echocardiography compared with MRI. Heart. 2014;100(24):1933–8.PubMedCrossRef

101.

Kumar R, Jelnin V, Kliger C, et al. Percutaneous paravalvular leak closure. Cardiol Clin. 2013;31:431–40.PubMedCrossRef

102.

Altiok E, Frick M, Meyer CG, Al Ateah G, Napp A, Kirschfink A, et al. Comparison of two- and three-dimensional transthoracic echocardiography to cardiac magnetic resonance imaging for assessment of paravalvular regurgitation after transcatheter aortic valve implantation. Am J Cardiol. 2014;113(11):1859–66.PubMedCrossRef

103.

Thavendiranathan P, Liu S, Datta S, Walls M, Nitinunu A, Van Houten T, et al. Automated quantification of mitral inflow and aortic outflow stroke volumes by three-dimensional real-time volume color-flow Doppler transthoracic echocardiography: comparison with pulsed-wave Doppler and cardiac magnetic resonance imaging. J Am Soc Echocardiogr. 2012;25(1):56–65.PubMedCrossRef

104.

Cawley PJ, Hamilton-Craig C, Owens DS, Krieger EV, Strugnell WE, Mitsumori L, et al. Prospective comparison of valve regurgitation quantitation by cardiac magnetic resonance imaging and transthoracic echocardiography. Circ Cardiovasc Imaging. 2013;6(1):48–57.PubMedCrossRef

105.

Merten C, Beurich HW, Zachow D, Mostafa AE, Geist V, Toelg R, et al. Aortic regurgitation and left ventricular remodeling after transcatheter aortic valve implantation: a serial cardiac magnetic resonance imaging study. Circ Cardiovasc Interv. 2013;6(4):476–83.PubMedCrossRef

106.

Bartel T, Müller S. Intraprocedural guidance: which imaging technique ranks highest and which one is complementary for closing paravalvular leaks? Cardiovasc Diagn Ther. 2014;4(4):277–8.PubMedCentralPubMed

107.

Bartel T, Müller S, Biviano A, Hahn RT. Why is intracardiac echocardiography helpful? Benefits, costs, and how to learn. Eur Heart J. 2014;35(2):69–76.PubMedCentralPubMedCrossRef

108.

Rodríguez Muñoz D, Lázaro Rivera C, Zamorano Gómez JL. Guidance of treatment of perivalvular prosthetic leaks. Curr Cardiol Rep. 2014;16(1):430.PubMedCrossRef

Titel: Imaging During Percutaneous Valvular Heart DiseaseInterventions: Is More Better or Less?
verfasst von: Alejandra Carbonell San Román
José Luis Zamorano Gómez
Publikationsdatum: 01.11.2015
Verlag: Springer US
Erschienen in: Current Cardiovascular Imaging Reports / Ausgabe 11/2015
Print ISSN: 1941-9066
Elektronische ISSN: 1941-9074
DOI: https://doi.org/10.1007/s12410-015-9359-4

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen